Goldman Sachs’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-11,700
Closed -$93K 7675
2015
Q1
$93K Sell
11,700
-6,800
-37% -$47.7K ﹤0.01% 6455
2014
Q4
$105K Sell
18,500
-34,000
-65% -$183K ﹤0.01% 6555
2014
Q3
$259K Sell
52,500
-2,800
-5% -$15.2K ﹤0.01% 5903
2014
Q2
$315K Buy
55,300
+52,200
+1,684% +$311K ﹤0.01% 5776
2014
Q1
$23K Sell
3,100
-3,300
-52% -$24.3K ﹤0.01% 6676
2013
Q4
$46K Sell
6,400
-7,500
-54% -$55.7K ﹤0.01% 6441
2013
Q3
$108K Sell
13,900
-13,500
-49% -$105K ﹤0.01% 6134
2013
Q2
$179K Buy
+27,400
New +$172K ﹤0.01% 5656

Goldman Sachs's ELX Position: Q2 2015 in Review

Goldman Sachs sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 72,569 shares — an estimated $578K sold.

Goldman Sachs first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $8.26M in Q2 2014. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Goldman Sachs reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Goldman Sachs sold 72,569 EMULEX CORP shares in Q2 2015, an estimated $578K.
  • Goldman Sachs first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Goldman Sachs's EMULEX CORP position peaked at $8.26M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.